北米の整形外科処置(医療デバイス)市場

◆英語タイトル:North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019
◆発行会社/調査会社:MicroMarketMonitor
◆商品コード:MMM-OR-1001
◆発行日:2015年3月
◆調査対象地域:北米
◆産業分野:医療デバイス
◆ページ数:95
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,650 ⇒換算¥296,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD4,505 ⇒換算¥504,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
MicroMarketMonitor社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[北米の整形外科処置(医療デバイス)市場]についてメールでお問い合わせはこちら
当調査レポートでは、北米の整形外科処置(医療デバイス)市場について調査・分析し、エグゼクティブサマリー、市場概観、成長要因・阻害要因、種類別分析、需要先別分析、主要国別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market.

The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market.

In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers.

The report has profiled the leading players of this market along with the developments (new product launches and partnerships, and joint ventures) by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the North America orthobiologics market.

The key players in the North America orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).

[Reasons to Buy the Report]
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the orthobiologics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

This report provides information with regards to established firms as well as new entrants/smaller firms, and thereby gauges the pulse of the market; it in turn helps deduce the market shares.

The market strategies with regards to this market are (market penetration, product development/innovation, market development, market diversification, and competitive assessment).

The report provides insights on the following pointers:
• Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the North American orthobiologics market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of Product approvals and Product recalls.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the North America orthobiologics market across geographies, exploits new clientele base and different pricing policies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the North America orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market.
• Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop the business strategies and manufacturing capabilities of leading players, thereby enhancing the bottom line of the companies in the North America orthobiologics market.
• Product/ Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs.

*** レポート目次(コンテンツ)***

TABLE OF CONTENTS

1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET SEGMENTATION & COVERAGE 11
1.3 STAKEHOLDERS 11

2 RESEARCH METHODOLOGY 12
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET 13
2.2 ARRIVING AT THE NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE 13
2.2.1 TOP-DOWN APPROACH 13
2.2.2 BOTTOM UP APPROACH 14
2.2.3 MACRO INDICATOR-BASED APPROACH 15
2.3 ASSUMPTIONS 16

3 EXECUTIVE SUMMARY 18

4 MARKET OVERVIEW 20
4.1 INTRODUCTION 20
4.2 ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET 21
4.3 MARKET DRIVERS AND INHIBITORS 22
4.4 KEY MARKET DYNAMICS 23

5 ORTHOBIOLOGICS MARKET, BY PRODUCT 24
5.1 INTRODUCTION 25
5.2 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2013-2019 (USD MN) 26
5.3 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2013-2019 (USD MN) 27
5.4 NORTH AMERICA BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013-2019 (USD MN) 29
5.5 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY,
2013-2019 (USD MN) 30
5.6 NORTH AMERICA BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY COUNTRY, 2013-2019 (USD MN) 31

6 ORTHOBIOLOGICS MARKET, BY END USER 33
6.1 INTRODUCTION 34
6.2 NORTH AMERICA HOSPITALS MARKET 35
6.3 NORTH AMERICA ORTHOPEDIC CLINICS MARKET 36
6.4 NORTH AMERICA OTHER END-USERS MARKET 37

7 ORTHOBIOLOGICS MARKET, BY GEOGRAPHY 38
7.1 INTRODUCTION 39
7.2 U.S. ORTHOBIOLOGICS MARKET 40
7.2.1 U.S. ORTHOBIOLOGICS MARKET, BY PRODUCT 41
7.2.2 U.S. ORTHOBIOLOGICS MARKET, BY END-USER 43
7.3 CANADA ORTHOBIOLOGICS MARKET 44
7.3.1 CANADA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
7.3.2 CANADA ORTHOBIOLOGICS MARKET, BY END-USER 47
7.4 MEXICO ORTHOBIOLOGICS MARKET 48
7.4.1 MEXICO ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
7.4.2 MEXICO ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 50

8 ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE 52
8.1 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS 52
8.2 MERGERS & ACQUISITIONS 53
8.3 NEW PRODUCT LAUNCHES 54
8.4 AGREEMENTS 56
8.5 OTHER DEVELOPMENTS 56

9 ORTHOBIOLOGICS MARKET, BY COMPANY 57
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC. 57
9.2 MEDTRONIC PLC 61
9.3 INTEGRA LIFESCIENCES CORPORATION 64
9.4 STRYKER CORPORATION 67
9.5 ZIMMER HOLDINGS, INC. 70
9.6 DEPUY SYNTHES COMPANIES (PART OF JOHNSON & JOHNSON FAMILY OF COMPANIES) 73
9.7 TORNIER, INC. 76
9.8 NUVASIVE, INC. 79
9.9 EXACTECH, INC. 81
9.10 GLOBUS MEDICAL, INC. 84
9.11 WRIGHT MEDICAL TECHNOLOGY, INC. 87
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

10 APPENDIX 91
10.1 CUSTOMIZATION OPTIONS 91
10.1.1 REGULATORY FRAMEWORK 91
10.1.2 EPIDEMIOLOGY DATA 91
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 91
10.1.4 IMPACT ANALYSIS 91
10.2 RELATED REPORTS 92
10.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 93
10.3.1 RT SNAPSHOTS 94

LIST OF TABLES

UU
TABLE 1 NORTH AMERICA ORTHOBIOLOGICS MARKET: MACRO INDICATOR, BY COUNTRY, 2011-2013 16
TABLE 2 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN) 21
TABLE 3 NORTH AMERICA ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS 22
TABLE 4 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY TYPE, 2013-2019 (USD MN) 23
TABLE 5 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 25
TABLE 6 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2013-2019 (USD MN) 27
TABLE 7 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2013-2019 (USD MN) 28
TABLE 8 NORTH AMERICA BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013-2019 (USD MN) 29
TABLE 9 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY,
2013-2019 (USD MN) 31
TABLE 10 NORTH AMERICA BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY COUNTRY, 2013-2019 (USD MN) 32
TABLE 11 NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY END USER,
2013-2019 (USD MN) 34
TABLE 12 NORTH AMERICA HOSPITALS MARKET, BY COUNTRY, 2013–2019 (USD MN) 35
TABLE 13 NORTH AMERICA ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013-2019 (USD MN) 36
TABLE 14 NORTH AMERICA OTHER END-USERS MARKET, BY COUNTRY, 2013-2019 (USD MN) 37
TABLE 15 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 39
TABLE 16 U.S. ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 42
TABLE 17 U.S. ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 43
TABLE 18 CANADA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
TABLE 19 MEXICO ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
TABLE 20 MEXICO ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 51
TABLE 21 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 52
TABLE 22 NORTH AMERICA ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS 53
TABLE 23 NORTH AMERICA ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES 54
TABLE 24 NORTH AMERICA ORTHOBIOLOGICS MARKET: AGREEMENTS 56
TABLE 25 NORTH AMERICA ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS 56
TABLE 26 BIOMET, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 58
TABLE 27 MEDTRONIC PLC: KEY FINANCIALS, 2009-2013 (USD MN) 61
TABLE 28 INTEGRA LIFESCIENCES CORPORATION: KEY FINANCIALS, 2010-2013 (USD MN) 64
TABLE 29 STRYKER CORPORATION: KEY FINANCIALS, 2009-2013 (USD MN) 67
TABLE 30 ZIMMER, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 71
TABLE 31 DEPUY SYNTHES COMPANIES: KEY FINANCIALS, 2011-2013 (USD MN) 74
TABLE 32 TORNIER, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 77
TABLE 33 NUVASIVE, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 79
TABLE 34 EXACTECH, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 81
TABLE 35 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 85
TABLE 36 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 87


LIST OF FIGURES

FIGURE 1 NORTH AMERICA ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE 11
FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM 13
FIGURE 3 TOP-DOWN APPROACH 14
FIGURE 4 BOTTOM-UP APPROACH 15
FIGURE 5 MACRO INDICATOR-BASED APPROACH 16
FIGURE 6 NORTH AMERICA ORTHOBIOLOGICS MARKET SNAPSHOT 19
FIGURE 7 NORTH AMERICA ORTHOBIOLOGICS MARKET PRODUCT, BY COUNTRY,
2014 (USD MN) 23
FIGURE 8 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2014 & 2019 (USD MN) 25
FIGURE 9 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2013-2019 (USD MN) 26
FIGURE 10 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2013-2019 (USD MN) 28
FIGURE 11 NORTH AMERICA BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013-2019 (USD MN) 29
FIGURE 12 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY,
2013-2019 (USD MN) 30
FIGURE 13 NORTH AMERICA BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY COUNTRY, 2013-2019 (USD MN) 32
FIGURE 14 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END USER, MARKET COMPARISON, 2014 & 2019 (USD MN) 34
FIGURE 15 NORTH AMERICA HOSPITALS MARKET, BY COUNTRY, 2013–2019 (USD MN) 35
FIGURE 16 NORTH AMERICA ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013-2019 (USD MN) 36
FIGURE 17 NORTH AMERICA OTHER END-USERS MARKET, BY COUNTRY, 2013-2019 (USD MN) 37
FIGURE 18 NORTH AMERICA ORTHOBIOLOGICS MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2013-2019 (USD MN) 39
FIGURE 19 U.S. ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 41
FIGURE 20 U.S. ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 41
FIGURE 21 U.S. ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 42
FIGURE 22 U.S. ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 43
FIGURE 23 U.S. ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 44
FIGURE 24 CANADA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 44
FIGURE 25 CANADA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
FIGURE 26 CANADA ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 46
FIGURE 27 CANADA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 47
FIGURE 28 CANADA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 47
FIGURE 29 CANADA ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 48
FIGURE 30 MEXICO ORTHOBIOLOGICS MARKET, MARKET OVERVIEW, 2014 & 2019 (%) 48
FIGURE 31 MEXICO ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
FIGURE 32 MEXICO ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 50
FIGURE 33 MEXICO ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 50
FIGURE 34 MEXICO ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 51
FIGURE 35 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 52
FIGURE 36 BIOMET, INC.: REVENUE MIX, 2013 (%) 57
FIGURE 37 CONTRIBUTION OF SPINE, BONE HEALING, & MICROFIXATION SEGMENT TOWARDS COMPANY REVENUE, 2011-2013 (USD MN) 58
FIGURE 38 MEDTRONIC PLC: REVENUE MIX, 2013 (%) 61
FIGURE 39 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN) 62
FIGURE 40 INTEGRA LIFESCIENCES CORPORATION: REVENUE MIX, 2013 (%) 64
FIGURE 41 CONTRIBUTION OF U.S. SPINE & OTHER SEGMENT TOWARDS COMPANY REVENUE, 2010-2013 (USD MN) 65
FIGURE 42 STRYKER CORPORATION: REVENUE MIX, 2013 (%) 67
FIGURE 43 CONTRIBUTION OF RECONSTRUCTIVE SEGMENT TOWARDS COMPANY REVENUE, 2010-2013 (USD MN) 68
FIGURE 44 ZIMMER HOLDINGS, INC.: REVENUE MIX, 2013 (%) 70
FIGURE 45 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN) 71
FIGURE 46 DEPUY SYNTHES COMPANIES: REVENUE MIX, 2013 (%) 73
FIGURE 47 TORNIER, INC.: REVENUE MIX, 2013 (%) 76
FIGURE 48 CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUE,
2009-2013 (USD MN) 77
FIGURE 49 NUVASIVE, INC.: REVENUE MIX, 2013 (%) 79
FIGURE 50 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUE,
2009-2013 (USD MN) 80
FIGURE 51 EXACTECH, INC.: REVENUE MIX, 2013 (%) 81
FIGURE 52 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 82
FIGURE 53 GLOBUS MEDICAL, INC.: REVENUE MIX, 2013 (%) 84
FIGURE 54 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN) 85
FIGURE 55 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX, 2013 (%) 87
FIGURE 56 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUE,
2011-2013 (USD MN) 88


*** レポートのキーワード ***

整形外科、治療、処置、医療デバイス

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMM-OR-1001 )"北米の整形外科処置(医療デバイス)市場" (英文:North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019)はMicroMarketMonitor社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。